Breaking Barriers: Public-Private Partnerships Revolutionizing Diabetes Research
Om avsnittet
Watch the full video on YouTube to learn how collaborations between academia and pharma are driving progress in diabetes care. In this episode, Dr. Melissa Thomas (Eli, Lilly & Company), Dr. Elizabeth Niemoller (Sanofi) and Prof. Dr. Michele Solimena (Helmholtz Zentrum München & Technical University of Dresden) join Vivienne Parry to unpack the power of partnerships.
The conversation covers:
- The evolution of public-private collaborations in diabetes research
- How projects like INNODIA and the Innovative Medicines Initiative (IMI) are accelerating translational breakthroughs
- The growing importance of patient advocates in study design and advocacy
- Why precompetitive science, shared data and early regulatory input are crucial for effective innovation
Listen now for a behind-the-scenes look at the partnerships shaping the future of diabetes care. Visit our speakers’ profiles to learn about their work:
Diabetes Insights - Breakthroughs and Innovators med EASD - European Association for the Study of Diabetes finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.